Skip to content

Ongoing hepatitis B virus replication associated with higher mortality for people with HIV

Menan Gérard Kouamé presenting at AIDS 2016. Photo by Liz Highleyman, hivandhepatitis.com

AbbVie 3D and 2D hepatitis C combos work well for people with HIV and HCV co-infection

Jürgen Rockstroh presenting at AIDS 2016. Photo by Liz Highleyman, hivandhepatitis.com

Sofosbuvir/velpatasvir shows high cure rate in HIV/HCV co-infection study

Norbert Bräu presenting at AIDS 2016. Photo by Liz Highleyman, hivandhepatitis.com

Incidence of liver cancer is increasing in people with HIV/HCV co-infection

Vaccination could have important role in control of UK HCV epidemic among people who inject drugs

Hepatitis C antigen testing could eliminate need for two-step HCV testing, reduce cost of access

Many US communities vulnerable to HIV outbreak due to unsafe injecting of prescription opioids

Sofosbuvir/ledipasvir regimens can cost less per cure than older hepatitis C treatments

New HCV therapies unaffordable to health systems and individuals